FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Repeat aloud to another person to boost your recall Oct 7, 9:08 am
Washington D.C, Oct 7 (ANI): A new study has revealed that repeating aloud to another person can boost your recall.
Full Story
Heavier the Internet use, higher the BP risk in teens Oct 7, 8:19 am
Washington D.C, Oct 7 (ANI): As per a recent study, teens, who spend hours on the Internet may be at risk for high blood pressure.
Full Story
When it comes to workouts, more is better for your heart Oct 6, 9:41 am
Washington D.C., Oct 6 (ANI): A new research has revealed that doing higher level of physical activity lowers the risk of developing heart failure rather than just following the U.S. physical activity guidelines recommendation.
Full Story
Don't worry, be happy! Positive emotions good for your heart Oct 6, 8:50 am
Washington D.C., Oct 6 (ANI): A new research has suggested that people who inculcate positive emotions and maintain positivity are less likely to develop any heart-disease than those who tend not to be happy.
Full Story